SEC Filings | Celldex Therapeutics

Form	Description	Filing date	View
8-K	Report of unscheduled material events or corporate event	Feb 24, 2004	View HTML 0001157523-04-001721.pdf 0001157523-04-001721.rtf
8-K	Report of unscheduled material events or corporate event	Feb 23, 2004	View HTML 0001047469-04-005312.pdf 0001047469-04-005312.rtf
SC 13G/A	An amendment to the SC 13G filing	Feb 18, 2004	View HTML 0000902664-04-000563.pdf 0000902664-04-000563.rtf
424B2	Form of prospectus filed in connection with primary offering of securities on a delayed basis	Feb 17, 2004	View HTML 0001047469-04-004728.pdf 0001047469-04-004728.rtf 0001047469-04-004728.xls
4	Statement of changes in beneficial ownership of securities	Jan 7, 2004	View HTML 0001179110-04-000636.pdf 0001179110-04-000636.rtf 0001179110-04-000636.xls
4	Statement of changes in beneficial ownership of securities	Jan 7, 2004	View HTML 0001179110-04-000669.pdf 0001179110-04-000669.rtf 0001179110-04-000669.xls
5	Annual filing director officer or owner of more than ten percent.	Jan 5, 2004	View HTML 0001179110-04-000156.pdf 0001179110-04-000156.rtf 0001179110-04-000156.xls
4	Statement of changes in beneficial ownership of securities	Jan 5, 2004	View HTML 0001179110-04-000245.pdf 0001179110-04-000245.rtf 0001179110-04-000245.xls
4	Statement of changes in beneficial ownership of securities	Jan 5, 2004	View HTML 0001179110-04-000250.pdf 0001179110-04-000250.rtf 0001179110-04-000250.xls
4	Statement of changes in beneficial ownership of securities	Jan 5, 2004	View HTML 0001179110-04-000257.pdf 0001179110-04-000257.rtf 0001179110-04-000257.xls

Data provided by Kaleidoscope.